fenyramidol

Fenyramidol is a centrally acting muscle relaxant and analgesic used for the symptomatic treatment of musculoskeletal pain and spasms. Chemically classified as an aminopyridine derivative, it exerts its therapeutic effects by acting on neural centers within the central nervous system, specifically the brain and spinal cord, to alleviate muscle stiffness and spasms without causing a significant reduction in muscle strength. First described in 1959, the drug has been indicated for conditions such as muscular rheumatism and painful skeletal muscle spasms. While it has been marketed under trade names like Cabral, its clinical use has been associated with potential hepatotoxicity, which has limited its availability in certain global markets.

Brand names

Cabral

Other names

phenyramidolfeniramidol2-(beta-hydroxyphenethylamino)pyridine